During a Case-Based Roundtable® event, Joshua K. Sabari, MD, continued discussion of key outcomes from the MARIPOSA trial and ...

Bristol Myers Squibb (NYSE:BMY) said that ongoing initiatives to cut costs will lead to the realization of $1.5B in annual ...

Avenzo to receive exclusive global license (excluding Greater China) for development, manufacturing and commercialization of potential best-in-class EGFR/HER3 ...

Mediation analyses demonstrated that eGFR is a strong mediator of these associations. Conclusion: These findings underscore the importance of TCA metabolites and renal function as conjunctive targets ...

Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610065, China Targeted Tracer ...

肺癌的主要亚型非小细胞肺腺癌有比较大的概率可以靶向治疗，对于亚裔的非小细胞肺腺癌患者来说，EGFR基因突变概率非常高，可以达到50%的突变 ...

When genes change, they alter the function and life cycle of healthy cells. Genetic changes cause cells to replicate abnormally ... Scientists have identified the following genes associated with ...

Epidermal growth factor receptor (EGFR) is expressed in 50% of NSCLCs, and its expression is correlated with poor prognosis. These two factors make EGFR and its family members prime candidates for ...

State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University ...

FIGURE 6. The proposed action mechanism oficotinib-triazole derivativesin ESCC cells. Icotinib-triazole derivatives inhibits cell proliferation, induces apoptosis and cell cycle arrest of ESCC cells ...